Brazil Mice Model Market Size, Share,Trends, Growth Analysis Report, 2030

Overview Request Sample Pages Request Customization Download PDF

You are viewing: Brazil Mice Model Market analysis

Part of: Mice Model Market (Global)

The Brazil Mice Model Market was valued at $12.33 Million in 2025 and projected to reach to $16.96 Million by 2030, representing a compound annual growth rate of 6.6%. Brazil's mice model market is positioned for moderate but consistent growth as the country strengthens its biomedical research capabilities and pharmaceutical development infrastructure.

Brazil Mice Model Market Trends and Insights

Brazil's growing investment in biomedical research and pharmaceutical development is driving demand for laboratory mice models, which are essential for preclinical testing and drug discovery.
The market in Brazil reflects increasing adoption of advanced research methodologies and regulatory compliance requirements that mandate animal model testing before human trials. The mice model market in Brazil is supported by expanding research institutions, academic centers, and contract research organizations (CROs) that require standardized laboratory animals for toxicology, efficacy, and safety studies.
Brazil's healthcare sector modernization and rising R&D expenditures are creating sustained demand for high-quality mice models through 2030.
As Brazil strengthens its position in Latin American pharmaceutical innovation, the mice model market is expected to benefit from increased collaboration with international research partners and enhanced breeding facilities..

Key Market Statistics

CAGR (2025-2030) 6.6% CAGR
Market Size, 2025 ~USD 12.33 Million
Forecast, 2030 ~USD 16.96 Million
Country Brazil

Brazil Mice Model Market Overview

Market Valuation :

Brazil's mice model market is valued at USD 12.33 million in 2025, with projections to reach USD 16.96 million by 2030, representing steady growth in the Latin American biomedical research sector.

Growth Trajectory :

The Brazilian market is expanding at a CAGR of 6.6% through 2030, driven by increased government funding for biomedical research and pharmaceutical development initiatives across the country.

Research Infrastructure Investment :

Brazil's growing investment in biomedical research facilities and pharmaceutical development centers is creating sustained demand for laboratory mice models essential for preclinical testing and drug discovery applications.

Regulatory Environment :

Strengthening regulatory frameworks for pharmaceutical testing in Brazil are mandating the use of validated animal models, including mice, for drug safety and efficacy assessments before clinical trials.

Brazil Mice Model Market Dynamics

Increased government funding, coupled with rising collaboration between Brazilian research institutions and international pharmaceutical companies, is driving demand for laboratory mice models.
The market benefits from Brazil's strategic focus on developing domestic drug discovery capabilities and reducing dependency on imported pharmaceutical solutions. Looking ahead to 2030, the Brazilian market will likely see expansion driven by emerging biotech companies, university research programs, and contract research organizations (CROs) establishing operations in the country.
However, growth will remain measured compared to global markets due to budget constraints and competition from alternative research models, positioning Brazil as a developing hub within the Latin American research landscape..

Related Ecosystem

Biotechnology

Top Technologies

Reagents
Polymerase Chain Reaction (PCR)
Stem Cells
Assay Kits
Flow Cytometers

Top Companies

Thermo Fisher Scientific Inc.
Merck KGaA
Danaher Corporation
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.

Key Takeaways

Brazil's mice model market is valued at USD 12.33 million in 2025 and will reach USD 16.96 million by 2030, growing at 6.6% CAGR.
Brazil's expanding biomedical research sector and pharmaceutical development initiatives are primary drivers of mice model demand.
Regulatory requirements for preclinical animal testing in Brazil mandate the use of standardized laboratory mice for drug safety and efficacy validation.
Brazil's growing CRO sector and academic research institutions are increasing procurement of high-quality mice models through 2030.

Mice Model Market Report Scope

Report Metric	Details
Base Year	2025
Fastest Growing Segment	SERVICES (Model Type & Service)
Forecast Period	2025�2030
Growth Rate	CAGR of 10% from 2025 to 2030
Largest Segment	MODEL TYPE (Model Type & Service)
Market Size Base Year (Billions)	~USD 1.7 (2025)
Revenue Forecast (Billions)	~USD 2.74 (2030)
Segments Covered	Model Type & Service, Type, Technology, Application, Therapeutic Area

Brazil Mice Model Market Report Segmentation

5 segment dimensions are covered across the global market.

By Model Type & Service

Model Type
Services

By Type

Breeding Services
Cryopreservation Services
Genetically Engineered Mice
Hybrid/Congenic Mice
Inbred Mice
Other Services
Outbred Mice
Quarantine Services
Rederivation Services

By Technology

Crispr/Cas9
Embryonic Stem Cell Injections
Microinjections
Nuclear Transfer Technique
Other Technologies

By Application

Drug Discovery & Development
Personalized Medicine
Research Applications

By Therapeutic Area

Cardiovascular Diseases
Immunology
Metabolic Diseases
Neurology
Oncology
Other Therapeutic Areas

Target Audience

Pharmaceutical Companies : Brazilian and international pharmaceutical firms need market intelligence to plan preclinical testing operations, establish local research partnerships, and optimize drug development timelines in Brazil.
Contract Research Organizations (CROs) : CROs operating in or entering Brazil require detailed market data to assess demand for preclinical services, benchmark pricing, and identify growth opportunities in the expanding biomedical research sector.
Laboratory Animal Suppliers : Breeders and suppliers of laboratory mice need market insights to understand demand patterns, customer segments, and growth projections to optimize breeding capacity and distribution strategies in Brazil.
Research Institutions : Brazilian universities and research institutes use market data to justify funding requests, benchmark their research capabilities, and identify collaboration opportunities with pharmaceutical and biotech partners.
Biotech Investors : Venture capital and private equity firms evaluating biotech investments in Brazil need market validation and growth forecasts to assess the viability and potential returns of research-focused ventures.

Key Companies in the Brazil Mice Model Market

Company	HQ	Ownership	Strongest segments
HORIZON DISCOVERY GROUP PLC	United Kingdom	Private Company	Screening,Research Reagents,Diagnostics,
LABORATORY CORPORATION OF AMERICA HOLDINGS	United States	Public Company	Routine and wellness diagnostics (chemistry, hematology, urinalysis, wellness programs),Specialty and esoteric testing (gene-based, oncology, infectious disease, women�s health, pharmacogenetics),Biopharma Laboratory Services (clinical trial, central lab, medical device and diagnostic R&D),
CHARLES RIVER LABORATORIES	United States	Public Company	Discovery and Safety Assessment,Research Models and Services,Manufacturing Solutions,
THE JACKSON LABORATORY	United States	Foundation/Charitable Institution	Mouse breeding and colony management services,Cryopreservation, recovery, and genetic resource management,Phenotyping, efficacy testing, and study-ready induced models,
INOTIV	United States	Public Company	Research Models and Services (RMS),Discovery and Safety Assessment (DSA) Services,BASi Scientific Instruments and Software,
JSR CORPORATION	Japan	Private Company	Digital Solutions (lithography, photoresists, packaging, CMP, display materials),Plastics (synthetic resins: ABS, AES, AS, ASA),Life Sciences (diagnostic reagents, bioprocess materials, drug discovery support),
BIOCYTOGEN	China	Public Company	Gene-Editing Services,Pharmacological Efficacy & Toxicology Services,Model Animals (Breeding & Sales),
SHANGHAI MODEL ORGANISMS CENTER, INC.	China	Public Company	Standard and disease mouse models (including toolbox and disease-specific strains),Customized genetically engineered models (KO, KI, humanized, transgenic),Preclinical services (non-GLP tox, PK, pharmacology/PD, phenotype analysis),
TRANS GENIC INC.	Japan	Public Company	Drug Discovery Support (non-clinical, bioequivalence, safety tests),Transgenic Models & Reagents (GM mice, antibodies, proteins, cells),Glycan Synthesis & Sugar Chain Analysis,
HARBOUR BIOMED	China	Public Company	Harbour Mice platform licensing and collaborations,Immunology clinical assets (e.g., batoclimab, HBM7020, HBM9378),Oncology clinical assets (e.g., porustobart, solid tumor portfolio),
GENOWAY	France	Public Company	Custom KO/KI mouse models,Custom KO/KI rat models,Humanized and immunodeficient rodent models (catalog and custom),
GEMPHARMATECH	China	Public Company	Standard GEMM catalog (knockout, conditional, knock-in, point-mutation, transgenic),Custom model generation and tool mice,Preclinical testing services,
VIVO BIO TECH LTD.	India	Public Company	In vivo and in vitro toxicity, PK/TK, and pharmacology services,SPF lab animals, rodent breeding, custom models, and lab diets,Genotoxicity screening and analytical services,

HORIZON DISCOVERY GROUP PLC

Horizon Discovery Group PLC is a United Kingdom-based private company founded in 2005 with 428 employees. The company operates in the life sciences sector, providing specialized research and development services.

LABORATORY CORPORATION OF AMERICA HOLDINGS

Laboratory Corporation of America Holdings is a major United States public company founded in 1995 with 66,385 employees. It is a leading provider of clinical laboratory services and drug development support.

CHARLES RIVER LABORATORIES

Charles River Laboratories is a United States public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services, research models, and safety assessment services.

THE JACKSON LABORATORY

The Jackson Laboratory is a United States foundation and charitable institution founded in 1929 with 2,100 employees. It is a premier research institution specializing in mammalian genetics and genomics.

INOTIV

Inotiv is a United States public company founded in 1974 with 1,996 employees. The company provides research models, services, and products for the pharmaceutical and biotechnology industries.

JSR CORPORATION

JSR Corporation is a Japan-based private company founded in 1948 with 7,997 employees. The company operates in advanced materials and life sciences sectors.

BIOCYTOGEN

Biocytogen is a China-based public company founded in 2008 with 1,443 employees. The company specializes in the development of genetically engineered animal models for research and drug development.

SHANGHAI MODEL ORGANISMS CENTER, INC.

Shanghai Model Organisms Center, Inc. is a China-based public company founded in 2000 with 848 employees. The company provides model organism services and products for biomedical research.

TRANS GENIC INC.

Trans Genic Inc. is a Japan-based public company founded in 1998 with 227 employees. The company develops and provides transgenic animal models for research applications.

HARBOUR BIOMED

Harbour Biomed is a China-based public company founded in 2016 with 272 employees. The company focuses on antibody and immunotherapy research and development.

GENOWAY

Genoway is a France-based public company founded in 1999 with 157 employees. The company specializes in the generation of genetically modified animal models for research.

GEMPHARMATECH

GemPharmatech is a China-based public company founded in 2017 with 1,590 employees. The company provides laboratory animal models and related research services.

VIVO BIO TECH LTD.

Vivo Bio Tech Ltd. is an India-based public company founded in 1987 with 174 employees. The company provides contract research services and laboratory animal models for pharmaceutical and biotechnology research.

Reasons to Buy this Report

Market Entry Strategy : Understand Brazil's specific market dynamics, growth drivers, and competitive landscape to develop targeted market entry strategies for suppliers and service providers in the mice model sector.
Investment Decision Support : Access validated market sizing and forecast data to support investment decisions in Brazilian biomedical research infrastructure, CROs, and laboratory animal breeding facilities.
Competitive Positioning : Identify market gaps and opportunities specific to Brazil's pharmaceutical and research sectors to position products and services competitively within this emerging market.
Regulatory Compliance Insights : Gain clarity on Brazil's regulatory requirements for laboratory mice models and preclinical testing standards to ensure compliant operations and market-appropriate offerings.
Growth Opportunity Assessment : Evaluate the 6.6% CAGR growth trajectory and identify high-potential segments within Brazil's biomedical research ecosystem for expansion and partnership opportunities.

Frequently asked questions

What is the current size of the mice model market in Brazil?

The mice model market in Brazil is valued at USD 12.33 million in 2025 and is expected to grow to USD 16.96 million by 2030.

What is the projected growth rate for Brazil's mice model market?

Brazil's mice model market is projected to grow at a compound annual growth rate (CAGR) of 6.6% from 2025 to 2030.

What are the main drivers of the mice model market in Brazil?

Key drivers include Brazil's expanding biomedical research infrastructure, increasing pharmaceutical R&D investments, regulatory requirements for preclinical testing, and growth in contract research organizations.

Which sectors in Brazil are the primary consumers of mice models?

Primary consumers in Brazil include pharmaceutical companies, contract research organizations (CROs), academic research institutions, and government-funded biomedical research centers.

How does Brazil's mice model market compare to other Latin American countries?

Brazil represents the largest and most developed mice model market in Latin America due to its advanced research infrastructure, pharmaceutical industry scale, and regulatory framework.

RESEARCH METHODOLOGY

This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global mice model market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include the International Mouse Phenotyping Consortium (IMPC), Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), European Molecular Biology Laboratory−European Bioinformatics Institute (EMBL-EBI), Swiss Laboratory Animal Science Association (SGV), Medical Research Council (MRC), Asian Mouse Mutagenesis Resource Association (AMMRA), Department of Biotechnology (DBT) (India), World Health Organization (WHO), United States Food and Drug Administration (US FDA), Annual Reports, SEC Filings, Investor Presentations, Research Journals, Press Releases, and financial statements. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

The following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate & validate the total size of the mice model market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Data Triangulation

The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

An animal model is a valuable resource in biomedical research, chosen for its ability to replicate certain aspects of biological processes or diseases observed in humans. A mouse model is a genetically engineered or naturally occurring mouse strain used in biomedical research to mimic human diseases or conditions. These models are valuable for their biological similarity to humans, ability to be genetically manipulated, and cost-effectiveness, enabling researchers to study disease mechanisms and test novel drug therapies efficiently. Mice share over 95% of human DNA and are biologically similar to humans, thereby being susceptible to similar diseases due to the genetic build-up.

Stakeholders

Manufacturers & Distributors of Mice Models
CROs & CDMOs
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Market Research & Consulting Firms
Researchers & Scientists
Regulatory Authorities & Institutes

Report Objectives

To define, describe, and forecast the global mice model market based on model type & service, technology, therapeutic area, application, product end user, service end user, and region
To provide detailed information regarding the leading factors driving the growth of the market (such as drivers, restraints, challenges, and opportunities)
To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall mice models market
To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
Track & analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the mice models market.
To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the mice model market.

Get the Full Mice Model Market Report

Full forecast, segment splits, and company analysis for all Mice Model Market.

Download Sample Pages Buy Report

REPORT COVERAGE

＋

Report Description
Market Overview
Market Dynamics
Related Ecosystem
Key Takeaways
Market Scope
Report Segmentation
Target Audience
Key Companies